1-(4,6-Dimethylpyrimidin-2-yl)-1H-pyrazol-5-amine

Catalog No.: 
ACNKQY064
CAS No.: 
1152964-30-1
Molecular Formula: 
C9H11N5
Molecular Weight: 
189.22
1-(4,6-Dimethylpyrimidin-2-yl)-1H-pyrazol-5-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$235.00InquiryInquiry
100mg98%$338.00InquiryInquiry
250mg98%$475.00InquiryInquiry
1g98%$943.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4,6-Dimethylpyrimidin-2-yl)-1H-pyrazol-5-amine
IUPAC Name1-(4,6-dimethylpyrimidin-2-yl)-1H-pyrazol-5-amine
MDL No.MFCD11641434
Molecular FormulaC9H11N5
Molecular Weight189.22
SMILESNC1=CC=NN1C2=NC(C)=CC(C)=N2
InChI KeyADTCQYGRFJTRLR-UHFFFAOYSA-N
Synonym1-(4,6-dimethylpyrimidin-2-yl)-1H-pyrazol-5-amine;1H-Pyrazol-5-amine, 1-(4,6-dimethyl-2-pyrimidinyl)-
CAS No.1152964-30-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACNKQY064 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBFZJ823 route compound structure diagram
    ACBFZJ82314284-93-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNKQY064 route product structure diagram
    ACNKQY0641152964-30-1
Inquiry

2. ACNKQY064 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNKQY064 route product structure diagram
    ACNKQY0641152964-30-1
Inquiry

3. ACNKQY064 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNKQY064 route product structure diagram
    ACNKQY0641152964-30-1
Inquiry

Comments (0)